Forgot your password ?

 login: 

  Why you need to be registered

 password: 

 Register 

Current issueArchivesubscribeInstructions to Authors

search by
Google





subscribe on the news  

 

Pay Color Illustration
 


Medline

PubMed, a service of the National Library of Medicine

World Oncology Network

R.E.Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology



Vol. 28, No. 3, 2006 (October)

Content

MOLECULAR AND CLINICAL CONDITIONS ASSOCIATED WITH VENOUS THROMBOEMBOLISM IN ONCOLOGICAL PATIENTS

 

P. Di Micco1, 2, *, M. Amitrano3, A. Niglio4, A. Fontanella1

1Division of Internal Medicine, Buonconsiglio Fatebenefratelli Hospital of Naples, Naples, Italy
2Department of Biochemistry and Medical Biotechnology and CEINGE SCARL, Federico II University of Naples, Naples, Italy
3Division of Angiology, A.O.R.N. G. Moscati, Avellino, Italy
4IV Division of Internal Medicine, Second University of Naples, Naples, Italy

Abstract. The association between cancer and thrombophilia has been known since 1865 since Trousseau described it. However in the last three decades an increased interest has been raised on this issue related to several molecular and condition that are involved in the daily management of oncological patients. This brief review has been focused on molecular conditions underlying cancer acquired thrombophilia then to further clinical aspects inducing thrombophilia in oncological patients such as surgery, chemotherapy, concomitant medical illness and inherited thrombophilia.

Key Words: cancer, thrombophilia, hypercoagulable state, inherited thrombophilia, chemotherapy

Language:  English

[full text]




Copyright (c) MORION 1999-2008

Current issue | Archive | subscribe | Instructions to Authors | E-Mail to webmaster